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Abstract: Haliclona tubifera, marine sponge species abundant in Brazilian coastline, 
presents only a few papers published in the literature. Recently, we have reported the 
isolation of two modified C18 sphingoid bases: (2R,3R,6R,7Z)-2-aminooctadec-7-ene-1,3, 
6-triol and and (2R,3R,6R)-2-aminooctadec-1,3,6-triol. In order to continue our research, in 
this work aimed at the biological investigation of fractions that led to the isolation of these 
compounds. We evaluated the cytotoxic effect of marine sponge H. tubifera fractions in 
glioma (U87) and neuroblastoma (SH-SY5Y) human cell lines. In addition, considering the 
link between cancer, imbalance of reactive oxygen species and coagulation disorders, we 
also investigated the in vitro effects on blood coagulation and their redox properties. We 
showed that the ethyl acetate (EtOAc) fraction, rich in sphingoid bases, had important 
cytotoxic effects in both cancer cell lines with an IC50 < 15 μg/mL and also can inhibit the 
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production of peroxyl radicals. Interestingly, this fraction increased the recalcification time of 
human blood, showing anticoagulant properties. The present study indicates the sphingosines 
fraction as a promising source of chemical prototypes, especially multifunctional drugs in 
cancer therapy. 
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1. Introduction 
Cancer is considered a leading cause of death worldwide and estimates reports that, in 2030,  
27 million incident cases of cancer and 17 million of deaths are expected [1]. Among several kinds of 
cancers, brain tumors are a serious and life-threatening condition, mainly because they can destroy and 
compress normal brain tissue, causing several types of damage [2]. In addition, the severity of this kind 
of tumor has been associated with metastatic processes [3]. Gliomas are considered the most devastating 
primary tumors in the brain [4], while neuroblastoma is the most common extracranial solid cancer in 
childhood [5]. 
A strong link between cancer and hypercoagulation has been reported. Approximately 50 percent of 
patients with a solid tumor have thromboses. Moreover, 95 percent of patients with cancer showed 
activation in the coagulation system [6,7]. These tumors have been linked with increased tissue factor 
(TF), which is the main physiological activating player of the blood clotting extrinsic system. TF is 
produced as part of an inflammatory response, activated by the presence of a tumor, considered a foreign 
organism [8]. 
Reactive oxygen species (ROS) and oxidative stress play an important role in the etiology and 
progression of pathological processes. A leading cause of cancer is associated with increased intrinsic 
ROS stress, due to mitochondrial dysfunction, oncogenic stimulation and increased metabolic activity [9,10]. 
Moreover, oxidative stress affects circulating proteins and is associated with an abnormal coagulative 
pattern [11]. 
Despite the variety of drugs for cancer treatment, issues around therapeutic selectivity of antineoplastics 
and phenotype of resistance to multiple drugs give support to the search for new molecules with 
antiproliferative properties and, most importantly, new therapeutic modalities [10]. In this context,  
the marine environment, and especially marine sponges, appeared as a potential source of biologically 
active compounds [12]. Among marine sponges, the genus Haliclona has been widely studied, with 
approximately 150 papers indexed on Pubmed. On the other hand, Haliclona tubifera, a species abundant 
in Brazilian coastline, presents only a few papers published in the literature, by our research group. The 
first one, about biological properties in crude extracts [13]. Recently, we have reported the isolation of 
two modified long-chain sphingoid bases, named Halisphingosines A and B (Figure 1), and the absolute 
configuration of these compounds was also assigned [14]. 
In order to continue our study with the marine sponge Haliclona tubifera, this research aimed at  
the biological investigation of fractions that led to the isolation of sphingoid bases. In this sense, we 
evaluated the cytotoxic effect of fractions of H. tubifera in U87 human glioma and SH-SY5Y human 
neuroblastoma cell lines. Moreover, considering the link between cancer, imbalance of reactive oxygen 
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species and coagulation disorders, we also investigated the in vitro effects on blood coagulation and their 
redox properties. 
 
Figure 1. Sphingoid bases isolated from EtOAc fraction of H. tubifera: (2R,3R,6R,7Z)-2-
aminooctadec-7-ene-1,3,6-triol (1); and (2R,3R,6R)-2-aminooctadec-1,3,6-triol (2) [14]. 
2. Results and Discussion 
2.1. Cytotoxic Evaluation 
The cytotoxic results of H. tubifera fractions in U87 human glioma and SH-SY5Y human 
neuroblastoma cell lines are shown in Table 1. We can observe that the fractionation allows find the main 
active fraction, since the EtOAc fraction showed a significant drop in cancer cell lines viability while 
hexane and aqueous fractions did not produce any cytotoxic effect after treatment for 24 h. EtOAc 
fraction trigged a cytotoxic effect slightly higher for glioma cells, with an IC50 = 12.47 μg/mL, compared 
with the results on neuroblastoma cells that had an IC50 around 17 μg/mL. 
Table 1. In vitro growth inhibitory activity against human glioma and neuroblastoma cell 
lines of H. tubifera fractions. 
H. tubifera Fractions
IC50 (μg/mL) a 
U87 SH-SY5Y 
Ethyl Acetate 12.47 ± 1.28 16.72 ± 1.24
Aqueous na na 
Hexane na na 
a All values given are the mean ± SEM. na: not active. 
The potential biological effects of the marine sponge H. tubifera were first reported by Monks and 
coworkers, which reported the cytotoxicity of the organic extract against colorectal cancer (HT-29), lung 
cancer (NCI-H460) and another glioma tumor cell line (U-373), with an IC50 of about 30 μg/mL [13]. 
Our results demonstrated a cytotoxic effect using others cancer cell lines and a reduction in IC50, after 
fractionation of the extracts. 
The EtOAc fraction of H. tubifera is mainly constituted by sphingoid bases through analysis using 
TLC (ninhydrin bands) and 1H NMR spectrum. The major compound was isolated as an N-Boc 
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derivative and identified as (2R,3R,6R,7Z)-2-aminooctadec-7-ene-1,3,6-triol (Halisphingosine A) [14]. 
We also characterized another, minor, new C18 sphingoid of H. tubifera EtOAc fraction, structurally 
related to Halisphingosine A (without a double bond in C-7), named Halisphingosine B (Figure 1) [14]. 
Efforts are being performed to synthesize these compounds to test for biological activities. 
Sphingosines are gaining recognition as important signaling mediator of apoptosis, mainly because 
they are not exclusively confined to membrane fractions, thus, being an ideal second messenger. Possible 
mechanisms involved in sphingosine-mediated cell death are related with it potential to modulate 
kinases, mainly: Protein kinase C (PKC), protein kinase A (PKA) and protein kinase Cδ (PKCδ).  
The activation of PKA and cleaving of PKCδ are associated with the regulation of dimeric 14-3-3  
protein function, which displays a vital clue of control pro-apoptotic mediators, such as Bad and  
signal-regulating kinase 1 (ASK-1). The activation of Jun N-terminal kinases (JNK) is subsequently 
regulated by ASK-1 [15]. 
Research studies have shown that the sphingolipid biosynthetic pathway is activated in response  
to stress conditions, leading to the accumulation of ceramide and sphingosine in apoptotic cells [15]. 
Considering that Halisphingosines A and B are the major compounds of the EtOAc fraction of  
H. tubifera, these sphingosines could be the substrate of ceramide synthase and sphingosine kinase, as shown 
in Figure 2. The action of these enzymes can convert sphingosine to ceramide by a scavenger pathway 
or be converted to sphingosine-1-phosphate (S1P). Ceramide exert antiproliferative effects inducing 
apoptotic mediators, whereas S1P promotes cell survival and inhibition of apoptosis [16–18]. 
Specifically, for the cell lines tested in our work, Munoz-Sáez and coworkers [19] showed that all doses 
tested for S1P protects necrosis in neuroblastoma cells (SH-SY5Y). On the other hand, Bernhart and 
coworkers [20] revealed the importance of sphingolipid synthesis and signaling for attenuating the 
proliferation of U87MG glioma cells. In this sense, we can infer that the possible cytotoxic mechanism 
of the EtOAc fraction of H. tubifera is associated with an induction of apoptotic mediators and also due 
to the production of metabolites (ceramides). 
 
Figure 2. Sphingolipid biosynthetic pathway, showing enzymes (in red) that Halisphingosines 
A and B could be substrate. 
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2.2. Effects on Blood Coagulation 
Considering the correlation of cancer and hypercoagulation condition, the effects of H. tubifera 
fractions upon clotting, through calcium-induced clotting time of citrated human plasma was analyzed. 
We demonstrated that, in addition to antitumor activity, the EtOAc fraction of H. tubifera also affected 
blood coagulation. Figure 3A shows the anticoagulant activity of the EtOAc fraction in a dose-dependent 
manner. All concentrations tested (1.0–100 μg/mL) changed the clotting time, comparing to the control. 
In the highest concentration tested, a significantly longer recalcification time was observed 
(approximately 9 min, Figure 3B), while the control plasma took approximately over 6 min to  
initiate coagulation. 
 
Figure 3. (A) Effect of marine sponge H. tubifera on blood coagulation: Anticoagulant 
activity for the EtOAc fraction; (B) Representative profile of the highest concentration that 
exhibited anticoagulant activity; Bars represent mean ± SEM. Asterisk (*) used when  
p < 0.05 compared to control (1-way ANOVA followed by Tukey’s test). 
The hypercoagulation process in patients with cancer is mainly caused by the tumor growing,  
neo-angiogenesis and dysfunction of affected organs [6]. The marine environment plays an important 
role in the search for anticoagulant products, and the vast majority of these compounds are 
polysaccharides [21–23]. Nevertheless, only a few anticoagulant products were isolated from marine 
sponges: A sesquiterpene from Coscinoderma mathewsi [24] and a peptide from the Australian sponge 
Lamellodysidea chlorea [25]. 
2.3. Redox Properties 
The redox properties of the marine sponge H. tubifera fractions were evaluated based on the capacity 
of samples to scavenge peroxyl radicals, generated by thermal decomposition of AAPH and compared 
with the antioxidant standard Trolox (water-soluble vitamin E analog). Significant dose-dependent 
antioxidant effects of EtOAc and aqueous fractions are shown in Figure 4. The EtOAc fraction at 25 μg/mL 
had an AUC similar to that of Trolox; however, could not inhibit the production of free radicals at initial 
time to the same extent as Trolox (Figure 5). The aqueous fraction (50 μg/mL), besides inhibiting free 
radicals, such as Trolox, sustains this effect for longer periods (Figure 5). The Trolox equivalent 
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antioxidant capacity (TEAC) allowing to comparing antioxidant activity of fractions and results, are 
summarized in Table 2. Both fractions presented a similar TEAC value, though the EtOAc fraction was 
slightly more potent to scavenge free radicals than the aqueous fraction. 
Table 2. Antioxidant effect expressed as Trolox equivalent antioxidant capacity (TEAC) of 
H. tubifera fractions. 
H. tubifera Fractions TEAC (μM Trolox/g Marine Sponge) 
Ethyl Acetate 8.0 
Aqueous 5.22 
Hexane na 
na: not active. 
 
Figure 4. TRAP from marine sponge H. tubifera: the EtOAc fraction (A); and the aqueous  
fraction (B) The effect of different concentrations of fractions on free radical induced 
chemiluminescence (CL) was measured as AUC. Trolox (0.05 μg/mL) and was used as a 
standard antioxidant. Bars represent mean ± SEM. Asterisk (*) used when p < 0.05 compared 
to control (1-way ANOVA followed by Tukey’s test).  
 
Figure 5. CL intensity (% cpm) measured after the addition of H. tubifera fractions. The CL 
profile of samples in concentration that exhibited similar AUC with the standard Trolox  
is represented. 
Mar. Drugs 2015, 13 5558 
 
 
The visualization of ninhydrin positive bands as for EtOAc fraction was not possible through the 
analysis of TLC for aqueous fraction. Thus, we can infer that the inhibition of free radicals by aqueous 
fractions should be produced by other compounds but not by sphingoid bases. The negative results for 
cytotoxic and anticoagulant assays also corroborate that the chemistry composition of the aqueous 
fraction do not present Halisphingosines A and B. 
Moreover, oxidative stress may promote an abnormal coagulative pattern and alter the structure and 
function of coagulative proteins [26], and play an important part in the initiation and progression of 
cancer [27]. Among the tested fractions, the EtOAc fraction also showed highest activity to scavenge 
peroxyl radicals, in a chemioluminescence assay. Several in vitro, in vivo, and epidemiological studies 
have demonstrated that antioxidants exert cancer-preventive potential [28]. Strategies that modulate the 
cellular redox potential are being applied to kill cancer cells [29] and antioxidants may be able to slow 
down or inhibit the progression of premalignant lesions to cancer [30]. 
3. Experimental Section 
3.1. Materials 
MTT (3-(4,5-dimethyl)-2,5-diphenyl tetrazolium bromide), Hepes, Trolox and Warfarin were purchased 
from Sigma-Aldrich (St. Louis, MO, USA). Methanol, Ethyl Acetate and Hexane (high-performance 
liquid chromatography (HPLC) grade) were obtained from Tedia (Fairfield, CA, USA). 
3.2. Sponge Collection 
Samples of marine sponge Haliclona tubifera were collected manually at depths of between 10 and 15 m, 
in locations along the coastline of the State of Santa Catarina, Brazil. A specimen of the sponge was 
deposited at the Museu de Ciências Naturais, Porifera collection, of the Fundação Zoobotânica do Rio 
Grande do Sul, Brazil. 
3.3. Preparation of Extracts and Fractions 
The marine sponge samples were previously freeze-dried and, then, extracts were prepared using an 
Ultra-Turrax system (Marconi, Piracicaba, SP, Brazil) with methanol. The raw methanol extracts were 
partitioned with other solvents to obtain the initial aqueous, hexane and ethyl acetate fractions. Firstly, 
the volume of the methanol extract was reduced. Then, 10% water was added. The methanol-aqueous 
suspension was partitioned against hexane. Then, methanol was evaporated using a rotary evaporator 
(Büchi Labortechnik AG, Flawil, Switzerland). The remaining aqueous suspension was partitioned 
against ethyl acetate. 
3.4. Cell Cultures 
The human glioma (U87) and human neuroblastoma (SHSY5Y) cell lines were obtained from 
American Type Culture Collection (Rockville, MD, USA). Glioma cells were grown and maintained in 
low glucose Dulbecco’s modified Eagle’s medium (DMEM; Gibco BRL, Carlsbad, CA, USA), containing 
0.1% fungizone, 100 U/L gentamicin and supplemented with 10% fetal bovine serum, and 
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neuroblastoma cells in a mixture 1:1 of Ham’s F12 and Dulbecco Modified Eagle Medium (DMEM) 
supplemented with 10% heat-inactivated FBS, 2 mM of glutamine, 0.28 μg/μL of gentamicin and 250 μg 
of amphotericin B. Cells were plated in 96-well plates (104/well) and kept at 37 °C in a humidified 
atmosphere with 5% CO2. Every 3 days, cell media was replaced and all treatments were performed 
when cell confluence reached 70%–80%. 
3.5. Treatments 
Aqueous and organic fractions were dissolved in water and dimethylsulfoxide (DMSO), to final 
concentrations of 10 mg/mL and 50 mg/mL (w/v), respectively. Successive dilutions were made with 
DMEM medium to final concentrations, ranging from 1.0 to 100 μg/mL. The cultures were treated with 
sponge extracts and fractions for 24 h. DMSO (0.25% final concentration) was proven not to affect the 
experiments. Control cultures were performed identically, but without extracts. 
3.6. Assessment of Glioma and Neuroblastoma Cell Viability 
Cell viability was performed by the quantification of the 3-(4,5 dimethylthiazole-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) reduction to a blue formazan product by viable cells. After treatments, the medium was 
discarded and a new medium containing 0.5 mg/mL MTT was added. The cells were incubated for  
45 min at 37 °C in a humidified atmosphere with 5% CO2. At the end of the incubation, this medium 
was removed and DMSO was added to solubilize formazan crystals for 30 min. Absorbance was 
measured at 550 nm (test) and 690 nm (reference) in a SoftMax Pro Microplate Reader (Molecular 
Devices®, Sunnyvale, CA, USA). The half maximal inhibitory concentration values (IC50) were 
estimated from a semilog plot of fractions and extract concentrations versus percentage of inhibition of 
tumor cell lines growth. 
3.7. Evaluation of Antioxidant Activity Using the Total Reactive Antioxidant Potential Method 
The total reactive antioxidant potential (TRAP) is extensively employed to verify the antioxidant capacity 
of samples in vitro. This method is based on the quenching of luminol-enhanced chemiluminescence 
(CL) derived from the thermolysis of 2,20-azo-bis (2 amidinopropane)dihydrochloride (AAPH) as the 
free radical source [31]. The stock solution was prepared with AAPH (10 mM). Luminol (8 nM) in a 
glycine buffer (0.1 M; pH 8.6) was added. The system was stabilized under constant light intensity (2 h) 
before the first reading. After, 20 μL of each sample, Trolox or system (glycine buffer) were placed in a 
96 cell-plate and the stock solution was adjusted to a final concentration of 200 μL. The CL emitted by 
the free radical reaction was quantified in a liquid scintillator counter (Wallac 1409, Perkin Elmer, 
Boston, MA, USA, with 10 s defined as a count time, for 3000 s). The samples (concentration of 50 mg/mL) 
were adjusted with glycine buffer to reach the final concentrations (1, 10, 25, 50 and 100 μg/mL).  
The final percentage of DMSO (0.25%) was proven to not change the chemiluminescence (CL) in the 
system. Trolox was prepared with glycine buffer. The results were expressed as plotting percentage of 
counts per minute (% cpm) versus time (s) and area under curve (AUC). Using the standard curve, which 
was obtained by plotting the concentration of Trolox and the AUC (between 0.05 and 0.4 μM Trolox), 
Trolox equivalent antioxidant capacity (TEAC) was estimated. 
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3.8. Clotting Assay 
Recalcification time (RT) was assessed using a SpectraMax microplate ELISA reader (Molecular 
Devices®, Sunnyvale, CA, USA) as described by Ribeiro and coworkers [32]. The procedure allows to 
follow clot formation and to use kinetic parameters for the coagulation process. Previously, 50 μL of 
human citrated platelet-poor plasma was incubated for 5 min, with 80 μL of 20 mM HEPES, pH 7.4, 
with or without (control) varied amounts of fractions (1, 10, 25, 50 and 100 μg/mL). Coagulation was 
triggered by adding CaCl2 to a final concentration of 10 mM, and clot formation was analyzed at 37 °C 
in the SpectraMax system at 650 nm taken at 15-s intervals, for 20 min. The final percentage of DMSO 
(0.25%) was proven not to affect blood coagulation. Clotting is indicated as a fast and sharp increase in 
the absorbance after a lag phase. A variation of 0.05 in the absorbance value (onset time) was defined as 
a measure of recalcification time, using the module included in the instrument’s software. 
3.9. Statistical Analysis 
The in vitro experiments were carried out with n = 3, while cell culture experiments were conducted 
with n = 6 in two independent experiments. Data were expressed as mean ± standard error of the mean 
(SEM). The results were evaluated by one-way analysis of variance (ANOVA) followed by Tukey’s Post 
Hoc Test. 
4. Conclusions 
In summary, this work sheds new light on the study of the marine sponge Haliclona tubifera,  
an abundant species from the southern Brazilian coast. We screened fractions obtained from the crude 
extract of H. tubifera along with their effects on human cancer cell lines, free radical and on blood 
coagulation in order to identify the main active fraction. The results demonstrate a potential cytotoxic 
activity in human glioma and neuroblastoma cell lines and also a strong antioxidant capacity of the 
sphingosines fraction. Moreover, our findings showed that this fraction exerts a significant anticoagulant 
effect using human citrated plasma samples. In addition, the relationship between the cytotoxic and 
anticoagulant activity of the sphingosines fraction of H. tubifera opens up perspectives for the research 
of new therapeutic modalities in the cancer therapy. Thus, our findings support to evaluate the biological 
effects of sphingoid bases previously isolated, and also to keep working on the isolated sphingoid bases 
from the EtOAc fraction of H. tubifera. 
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